根据 Gen Consulting 公司发布的市场研究报告, the global embolotherapy market is expected to reach approximately USD 4,794 百万, representing a CAGR of 6.5% 在预测期内 2022-2028.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global embolotherapy market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the embolotherapy industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, indication, procedure, 最终用户, 和地区. The global market for embolotherapy can be segmented by product: embolic agents, support devices. 在这些当中, the embolic agents segment was accounted for the highest revenue generator in 2021. Embolotherapy market is further segmented by indication: cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, gastrointestinal disorders. The cancer segment is estimated to account for the largest share of the global embolotherapy market. Based on procedure, the embolotherapy market is segmented into: trancatheter arterial embolization (TAE), transarterial chemoembolization (TACE), transarterial radioembolization (TARE). The trancatheter arterial embolization (TAE) segment held the largest share of the global embolotherapy market in 2021 预计在预测期内将持有其份额. On the basis of end user, the embolotherapy market also can be divided into: hospitals and clinics, 门诊手术中心 (ASCs), 其他的. 在 2021, the hospitals and clinics segment made up the largest share of revenue generated by the embolotherapy market. Embolotherapy market by region is categorized into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

副产品:
– embolic agents
– support devices

By indication:
– cancer
– neurological diseases
– peripheral vascular diseases
– urological and nephrological disorders
– gastrointestinal disorders

By procedure:
– trancatheter arterial embolization (TAE)
– transarterial chemoembolization (TACE)
– transarterial radioembolization (TARE)

按最终用户:
– hospitals and clinics
– 门诊手术中心 (ASCs)
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The market research report covers the analysis of key stake holders of the global embolotherapy market. Some of the leading players profiled in the report include Acandis GmbH, Balt Extrusion SAS, Boston Scientific Corporation, Cook Group Incorporated, Guerbet SA, 约翰逊 & 约翰逊, Kaneka Corporation, 美敦力公司, Meril Life Sciences Private Limited, Merit Medical Systems Inc., Penumbra, 公司, Sirtex Medical Limited, 史赛克公司, Terumo Corporation, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global embolotherapy market.
– To classify and forecast the global embolotherapy market based on product, indication, procedure, 最终用户, 地区.
– To identify drivers and challenges for the global embolotherapy market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global embolotherapy market.
– To identify and analyze the profile of leading players operating in the global embolotherapy market.

为什么选择这份报告
– Gain a reliable outlook of the global embolotherapy market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.